Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Sep 2026 is 1.85% vs 3.30% in Jun 2026
Consolidate Net Profit
QoQ Growth in quarter ended Sep 2026 is -8.27% vs -13.56% in Jun 2026
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Sep 2026 is -1.09% vs -4.61% in Jun 2026
Interest
QoQ Growth in quarter ended Sep 2026 is 63.76% vs -56.53% in Jun 2026
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2026 has fallen from Jun 2026
Compare Quarterly Results Of Gland Pharma With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2026 is 1.85% vs 3.30% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 23.32% vs 5.77% in Sep 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2026 is -8.27% vs -13.56% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 58.30% vs 12.32% in Sep 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2026 is -1.09% vs -4.61% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 54.21% vs 5.67% in Sep 2025
Quarterly - Interest
QoQ Growth in quarter ended Sep 2026 is 63.76% vs -56.53% in Jun 2026
YoY Growth in quarter ended Sep 2026 is -8.70% vs 27.99% in Sep 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2026 has fallen from Jun 2026
YoY Growth in quarter ended Sep 2026 has improved from Sep 2025